RIVM and EFSA optimise new calculation model for mixture risk assessment Plant protection products (PPPs) are products used in agriculture to protect crops against, for example, fungi, insects and weeds.
Participation rates in cancer population screening programmes continue to decline The number of participants in the population screening programmes for breast cancer, cervical cancer and colorectal cancer continues to decline. This decline has been going on for years, reaching its lowest point in 2020.
Metabolic disorder ALD added to newborn blood spot screening Since 1 October, the metabolic disorder adrenoleukodystrophy (ALD) has been added to the Dutch newborn blood spot screening. From now on, the blood of newborn boys will also be tested for this disorder. ALD in boys can be treated if it is detected in time.
Increase in percentage of positive tests, stabilisation in hospital admissions In the past week, from 21 to 27 April, the reported number of people who tested positive for COVID-19 increased slightly to 55,097 newly reported infections (+2%)*.
One in ten tests positive In the past week, from 14 to 20 April, the reported number of people who tested positive for COVID-19 increased by 5.3%, rising to 53,981 newly reported infections.
Support for ‘corona passport’, downward trend in compliance with visitor limits There seems to be widespread support for introducing a coronavirus passport, also referred to as ‘corona passport’.
Fewer coronavirus infections among people who kept distancing People who follow the advice to stay 1.5 apart from others are less likely to contract the coronavirus SARS-CoV-2.
Coronavirus monitoring in sewage research expanded and extended Since March 2020, RIVM has been working with the water boards in the Netherlands to monitor sewage for traces of the coronavirus SARS-CoV-2. The measurements are an important supplement to other COVID-19 studies.